小方制药
(603207)
| 流通市值：12.48亿 | | | 总市值：36.97亿 |
| 流通股本：5460.29万 | | | 总股本：1.62亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 425,897,267.01 | 281,930,889.08 | 145,694,452.27 | 525,280,851.39 |
| 营业收入 | 425,897,267.01 | 281,930,889.08 | 145,694,452.27 | 525,280,851.39 |
| 二、营业总成本 | 248,480,044.91 | 159,156,289.08 | 80,034,518.55 | 283,033,965.67 |
| 营业成本 | 169,802,128.45 | 110,234,359.64 | 56,930,079.08 | 183,850,904.17 |
| 税金及附加 | 4,413,896.76 | 2,420,981.28 | 1,210,670.56 | 4,792,521.44 |
| 销售费用 | 49,849,521.49 | 32,898,512.48 | 15,500,807.14 | 59,105,431.12 |
| 管理费用 | 15,838,151.75 | 9,966,469.13 | 4,927,941.9 | 19,067,152.43 |
| 研发费用 | 11,613,763.54 | 5,932,307.86 | 1,661,550.4 | 19,295,240.15 |
| 财务费用 | -3,037,417.08 | -2,296,341.31 | -196,530.53 | -3,077,283.64 |
| 其中:利息费用 | 24,785.15 | 17,956.89 | 4,805.31 | 26,736.66 |
| 其中:利息收入 | -3,072,232.47 | 2,321,885.65 | -204,340.59 | 3,183,924.7 |
| 三、其他经营收益 | | | | |
| 资产处置收益 | -5,641.59 | -5,641.59 | -5,641.59 | 110,619.47 |
| 资产减值损失(新) | -68,211.87 | -498.86 | 194,951.06 | -183,048.19 |
| 信用减值损失(新) | 937,928.18 | -53,685.12 | -505,808.33 | -1,853,993.68 |
| 其他收益 | 872,114.35 | 868,900.06 | 243,936.53 | 1,199,330.38 |
| 四、营业利润 | 179,153,411.17 | 123,583,674.49 | 65,587,371.39 | 241,519,793.7 |
| 加:营业外收入 | 1,392,492.33 | 0.08 | 0.08 | 373,263.29 |
| 减:营业外支出 | 168,184.78 | 120,000 | 124,582.28 | 665,847.01 |
| 五、利润总额 | 180,377,718.72 | 123,463,674.57 | 65,462,789.19 | 241,227,209.98 |
| 减:所得税费用 | 24,824,982.38 | 17,913,656.77 | 9,455,865.68 | 33,737,532.8 |
| 六、净利润 | 155,552,736.34 | 105,550,017.8 | 56,006,923.51 | 207,489,677.18 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 155,552,736.34 | 105,550,017.8 | 56,006,923.51 | 207,489,677.18 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 155,552,736.34 | 105,550,017.8 | 56,006,923.51 | 207,489,677.18 |
| 扣除非经常损益后的净利润 | 154,489,986.51 | 105,632,661.71 | 56,098,926.65 | 207,526,029.38 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.96 | 0.66 | 0.35 | 1.29 |
| (二)稀释每股收益 | 0.96 | 0.66 | 0.35 | 1.29 |
| 九、综合收益总额 | 155,552,736.34 | 105,550,017.8 | 56,006,923.51 | 207,489,677.18 |
| 归属于母公司股东的综合收益总额 | 155,552,736.34 | 105,550,017.8 | - | 207,489,677.18 |
| 公告日期 | 2026-10-24 | 2026-08-27 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |